Laura Bessen - Jul 18, 2024 Form 3 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Director
Signature
/s/ Jennifer Bush, Attorney-in-Fact
Stock symbol
ARTV
Transactions as of
Jul 18, 2024
Transactions value $
$0
Form type
3
Date filed
7/18/2024, 08:02 PM
Previous filing
Jun 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ARTV Director Stock Option (Right to Buy) Jul 18, 2024 Common Stock 13.7K $5.01 Direct F1
holding ARTV Director Stock Option (Right to Buy) Jul 18, 2024 Common Stock 3.42K $13.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting is monthly over a 36-month period starting March 3, 2022 in equal monthly amounts.
F2 100% of the shares vest upon the earlier of (i) the first anniversary of the initial public offering of the Issuer and (ii) date of the next annual meeting of stockholders of the Issuer.